Skip to content

AVRA SURGICAL ROBOTICS, INC.: 10-K filed 2013-04-01

What AVRA SURGICAL ROBOTICS, INC. reported in its annual report filed 2013-04-01 (fiscal FY 2012): 25 published measures, 62 facts as tagged in accession 0001213900-13-001553.

This filing

Form
10-K (annual report)
Filed
2013-04-01
Fiscal period
fiscal FY 2012
Accession
0001213900-13-001553 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AVRA SURGICAL ROBOTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-31851,509USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-313,330,661USD
At 2011-12-3110,308USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-31-1,901,276USD
At 2011-12-31-10,308USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-6,546,027USD366
2006-08-30 to 2012-12-31-6,730,018USD2316
2011-01-01 to 2011-12-31-29,103USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-2,402,987USD366
2006-08-30 to 2012-12-31-2,570,705USD2316
2011-01-01 to 2011-12-31-26,274USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,222,110USD366
2006-08-30 to 2012-12-313,389,828USD2316
2011-01-01 to 2011-12-3126,208USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-352,204USD366
2006-08-30 to 2012-12-31-352,204USD2316

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-31190,249USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,000,000USD366
2006-08-30 to 2012-12-313,000,000USD2316

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-7,118,296USD366
2006-08-30 to 2012-12-31-7,290,070USD2316
2011-01-01 to 2011-12-31-29,930USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-31511,116USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2006-08-30 to 2012-12-3116,273USD2316
2011-01-01 to 2011-12-313,229USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-313,330,661USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2006-08-30 to 2012-12-3125,000USD2316
2011-01-01 to 2011-12-3125,000USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-12-312,697,292USD366
2006-08-30 to 2012-12-312,697,292USD2316

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3138,479,238shares
At 2011-12-312,500,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-314,873,177USD
At 2011-12-31173,433USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-12-31-48,283USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-12-31-2,479,152USD
At 2011-12-31-10,308USD
At 2010-12-31-124,888USD
At 2009-12-31-94,156USD
At 2008-12-31-64,244USD
At 2007-12-31-33,443USD
At 2006-12-311,489USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-3110,637USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-7,118,296USD366
2006-08-30 to 2012-12-31-7,302,287USD2316
2011-01-01 to 2011-12-31-29,103USD365
2010-01-01 to 2010-12-31-30,732USD365
2009-01-01 to 2009-12-31-29,912USD365
2008-01-01 to 2008-12-31-30,801USD366
2007-01-01 to 2007-12-31-34,932USD365
2006-08-30 to 2006-12-31-28,511USD124

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-6,594,310USD366
2006-08-30 to 2012-12-31-6,778,301USD2316
2011-01-01 to 2011-12-31-29,103USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,421,004USD366
2006-08-30 to 2012-12-314,592,778USD2316
2011-01-01 to 2011-12-3129,930USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-3110,637USD366
2006-08-30 to 2012-12-3110,637USD2316

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,701,092USD366
2006-08-30 to 2012-12-311,756,092USD2316
2011-01-01 to 2011-12-3125,000USD365

Inspect the source

Entity
AVRA SURGICAL ROBOTICS, INC. / CIK 0001377040
Captured
SEC response SHA-256
97e88c5bb97ae480fd819ffa8cf7a28b67556bd6819922dca6b622a40fbf9173

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001377040.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))